Hani Gabra

Professor of Medical Oncology, Imperial College, London; Chief Medical Officer, BerGenBio

  • Garry Weston Centre, Hammersmith Hospital, 150 Du Cane Road, Shepherd's Bush London W12 0HS
  • www.imperial.ac.uk


Biography

Professor Gabra joined BerGenBio in September 2019 as Chief Medical Officer, based in Oxford UK.

He has extensive experience of preclinical cancer biology and clinical drug development, having previously been Vice President in Early Clinical Development at AstraZeneca in Cambridge, UK, concurrently holding the positions of Professor of Medical Oncology at Imperial College London and Honorary Consultant in Medical Oncology at Imperial College Healthcare NHS Trust (since 2003) and Adjunct Professor at the Centre for Cancer Biomarkers at University of Bergen (since 2016). He was previously Head of Medical Oncology, Director of the Ovarian Cancer Action Research Centre and Head of Imperial College Cancer Clinical Trials Unit, as well as Chief of Service of the West London Gynaecological Cancer Centre at Imperial College London. Prior to that he was Cancer Research UK Clinical Scientist and Honorary Clinical Senior Lecturer/Consultant in Medical Oncology at the CRUK Medical Oncology Unit in the University of Edinburgh.

Prof Gabra is an internationally recognised leader in translational research and gynaecological oncology. His research interests include tumour suppressor genes that regulate receptor tyrosine kinase networks (including AXL), the molecular basis of clinical platinum resistance, and all phases of ovarian cancer clinical research. He is the author of more than 200 peer reviewed publications and patents, with over 15,000 citations associated with his publications.

 

Education & Experience


Education

Title:
Ph.D
Degree:
Oncology and Molecular Genetics
Institution:
The University of Edinburgh
Date:
1992 - 1996
Country:
United Kingdom
Title:
MB ChB
Degree:
Medicine
Institution:
The University of Glasgow
Date:
1984 - 1987
Country:
United Kingdom


Experience

Title:
Chief Physician Scientist and Vice President head of Oncology Discovery Unit, Early Clinical Development IMED Biotech Unit
Organisation:
AstraZeneca Cambridge, UK
Date:
None
Title:
Consultant Medical Oncologist
Organisation:
Private Practice
Date:
since 2010
Title:
Honorary Consultant Medical Oncologist
Organisation:
Imperial College Healthcare NHS Trust
Date:
since 2003
Title:
Director
Organisation:
Ovarian Cancer Action Research Centre
Date:
2006 - 2016
Title:
Professor of Medical Oncology
Organisation:
Imperial College London
Date:
since 2003
Title:
Cancer Research UK Clinical Scientist
Organisation:
University of Edinburgh
Date:
1998 - 2003


Location

  • Garry Weston Centre, Hammersmith Hospital, 150 Du Cane Road, Shepherd's Bush London W12 0HS